Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY518674 Effects on HDL-C Metabolism
NCT00327002Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Jan 2006
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ly518674 in metabolic syndrome, dyslipidemia, sponsored by University of Pennsylvania. Started Jan 2006; status: completed.
02
Drugs
ly518674
03
Conditions
metabolic syndromedyslipidemia
Beyond the preview
Go deeper on NCT00327002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327002.